News

KBW analyst Kyle Voigt maintained a Hold rating on CME Group today and set a price target of $283.00. The company’s shares closed yesterday at $276.48. Elevate Your Investing St ...
Fintel reports that on July 24, 2025, UBS downgraded their outlook for CME Group (NasdaqGS:CME) from Buy to Neutral. Analyst ...
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $296.57, ...
J.P. Morgan analyst Ken Worthington maintained a Sell rating on CME Group on July 21 and set a price target of $245.00. The company’s shares closed yesterday at $274.64. Take advantage of TipRanks ...
CME Group's Q2 2025 sees record-breaking growth with 30.2M daily contracts, key retail and global gains, and strategic initiatives in tokenization.
Private equity proponents argue that one of the asset class’s biggest selling points is its low volatility compared with ...
Reports Q2 revenue $1.69B, consensus $1.68B. “Demand for CME Group (CME) benchmark futures and options reached an all-time ...
Bitcoin ( BTC) starts the last full week of July in “wait and see” mode as altcoins steal the spotlight. BTC price action continues to consolidate after $123,000 all-time highs, and liquidation levels ...
Bitcoin price action coils beneath an increasingly thick cloud of liquidity as PPI inflation cools beyond expectations in June. Bitcoin price targets include taking liquidity at around the $120,000 ...
RMR Group offers strong margins, portfolio growth, low leverage, and a 10% yield, appealing to both income and growth investors. Find out why RMR stock is a buy.
LONDON and SINGAPORE, July 10, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its quarterly international average daily volume (ADV) reached a ...
Exploring Analyst Ratings: An In-Depth Overview The perception of CME Group by financial experts is analyzed through recent analyst actions.